These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10849957)

  • 1. Risk of Pseudomonas aeruginosa cross-colonisation in patients with cystic fibrosis within a holiday camp--a molecular-epidemiological study.
    Hunfeld KP; Schmidt C; Krackhardt B; Posselt HG; Bargon J; Yahaf Y; Schäfer V; Brade V; Wichelhaus TA
    Wien Klin Wochenschr; 2000 Apr; 112(7):329-33. PubMed ID: 10849957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of evidence of transmission of Pseudomonas aeruginosa among cystic fibrosis patients attending health camps at the Dead Sea, Israel.
    Greenberg D; Yagupsky P; Peled N; Goldbart A; Porat N; Tal A
    Isr Med Assoc J; 2004 Sep; 6(9):531-4. PubMed ID: 15373310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa diversity in distinct paediatric patient groups.
    Tramper-Stranders GA; van der Ent CK; Wolfs TF; Kimpen JL; Fleer A; Johansen U; Johansen HK; Høiby N
    Clin Microbiol Infect; 2008 Oct; 14(10):935-41. PubMed ID: 18752596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
    Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U
    Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre.
    Van Daele SG; Franckx H; Verhelst R; Schelstraete P; Haerynck F; Van Simaey L; Claeys G; Vaneechoutte M; de Baets F
    Eur Respir J; 2005 Mar; 25(3):474-81. PubMed ID: 15738291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic.
    Vosahlikova S; Drevinek P; Cinek O; Pohunek P; Maixnerova M; Urbaskova P; van den Reijden TJ; Dijkshoorn L; Nemec A
    Res Microbiol; 2007 May; 158(4):324-9. PubMed ID: 17448645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
    Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
    Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AP-PCR typing of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
    Giordano A; Magni A; Graziani C; Sessa R; Quattrucci S; Cipriani P
    New Microbiol; 2001 Apr; 24(2):157-63. PubMed ID: 11346299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B; Petersen US; Høiby N
    APMIS; 1993 Feb; 101(2):168-75. PubMed ID: 8098219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of Pseudomonas aeruginosa from cystic fibrosis in Sicily: genome macrorestriction analysis and rapid PCR-ribotyping.
    Agodi A; Sciacca A; Campanile F; Messina C; Barchitta M; Sciacca S; Stefani S
    New Microbiol; 2000 Jul; 23(3):319-27. PubMed ID: 10939047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility.
    Mereghetti L; Marquet-van der Mee N; Loulergue J; Rolland JC; Audurier A
    Pathol Biol (Paris); 1998 May; 46(5):319-24. PubMed ID: 9769892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis.
    Ferroni A; Guillemot D; Moumile K; Bernede C; Le Bourgeois M; Waernessyckle S; Descamps P; Sermet-Gaudelus I; Lenoir G; Berche P; Taddei F
    Pediatr Pulmonol; 2009 Aug; 44(8):820-5. PubMed ID: 19598278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands.
    Brimicombe RW; Dijkshoorn L; van der Reijden TJ; Kardoes I; Pitt TL; van den Broek PJ; Heijerman HG
    J Cyst Fibros; 2008 Jan; 7(1):30-6. PubMed ID: 17532271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antimicrobial sensitivity patterns as markers of Pseudomonas aeruginosa cross-infection at a cystic fibrosis clinic.
    Williams T
    Br J Biomed Sci; 1997 Sep; 54(3):181-5. PubMed ID: 9499595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Pseudomonas aeruginosa in a tertiary referral teaching hospital.
    Bradbury RS; Champion AC; Reid DW
    J Hosp Infect; 2009 Oct; 73(2):151-6. PubMed ID: 19699556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs.
    Erlandsson M; Gill H; Nordlinder D; Giske CG; Jonas D; Nilsson LE; Walther S; Hanberger H
    Scand J Infect Dis; 2008; 40(6-7):487-94. PubMed ID: 18584536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
    Etherington C; Hall M; Conway S; Peckham D; Denton M
    J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.